U.S. Medical Equipment Stock News

NYSE:RYAN
NYSE:RYANInsurance

Ryan Specialty (RYAN) Is Up 5.8% After Q2 Beat, Dividend Hike And Buyback Completion – What’s Changed

In the past week, Ryan Specialty Holdings reported second-quarter 2026 results showing revenue of US$916.65 million and net income of US$42.32 million, alongside a quarterly dividend of US$0.13 per Class A share and completion of a US$300 million share repurchase program covering 6.71% of shares. Management also highlighted its disciplined acquisition engine and reiterated confidence in a durable platform, even as updated 2026 guidance anticipates some margin pressure despite continued...
NYSE:TDW
NYSE:TDWEnergy Services

Tidewater (TDW) Heads Into Q2 Earnings With Its Valuation Story Under Review

Why Tidewater’s Upcoming Q2 Earnings Matter For Investors Tidewater (TDW) is back in focus after confirming it will report Q2 2026 results after the market close on August 3. This earnings release is a key update for investors following mixed performance last quarter. See our latest analysis for Tidewater. Over the past year, Tidewater has combined a 43.71% year to date share price return with a 57.92% one year total shareholder return. However, momentum has cooled recently, with the share...
NYSE:J
NYSE:JProfessional Services

How LA Metro’s Zero-Emission Contract and Dividend Policy Will Impact Jacobs Solutions (J) Investors

Jacobs Solutions Inc. has declared a quarterly cash dividend of US$0.36 per share, payable on September 18, 2026 to shareholders of record as of August 21, 2026, and earlier this year LA Metro selected Jacobs, with Clark Construction Group, to design and build advanced zero-emission bus charging infrastructure at two key Los Angeles divisions. The LA Metro win positions Jacobs at the center of Los Angeles’ zero-emission transit preparations for the 2028 Olympic and Paralympic Games while...
NYSE:SF
NYSE:SFCapital Markets

Stifel Financial (SF) Posted Stronger Q2 Results, Does It Still Look Fairly Valued?

Stifel Financial (SF) reported second quarter 2026 results on July 22, with revenue of US$1,638.78 million and net income of US$226.48 million, alongside continued share repurchases during the period. See our latest analysis for Stifel Financial. The stronger second quarter results and ongoing buybacks come after a mixed price pattern for Stifel Financial, with a 15.39% 1 month share price return but a 3.07% decline year to date. At the latest share price of US$82.91, that sits alongside a...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Tetra Tech (TTEK) Lifts Guidance And Dividend, Is The Undervalued Case Already Priced In?

Q3 results and updated guidance set the tone for Tetra Tech Tetra Tech (TTEK) is back in focus after releasing third quarter earnings on July 29, 2026, alongside updated guidance for the fourth quarter and full year, plus a higher quarterly dividend. The company reported third quarter sales of $1,308.56 million compared with $1,369.82 million a year earlier. Net income was $109.58 million, slightly below $113.84 million in the prior year period. Basic and diluted earnings per share from...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

Lincoln Electric Holdings (LECO) Reported Higher Sales And Earnings, Is It Still A Bargain?

Lincoln Electric earnings update and what it means for investors Lincoln Electric Holdings (LECO) recently reported its second quarter and first half 2026 results, giving you fresh information on sales, earnings and ongoing dividend income to reassess the stock. For the second quarter ended June 30, 2026, Lincoln Electric reported sales of $1,219.66m compared with $1,088.67m in the same period last year. Net income was $158.52m compared with $143.40m a year earlier. Basic earnings per share...
NYSE:AU
NYSE:AUMetals and Mining

3 Dividend Stocks For Income Investors Watching Gold And Global Uncertainty

With inflation pressures still linked to energy markets and central banks keeping investors focused on interest rate paths, dependable income has fresh appeal. The Dividend Powerhouses (3%+ Yield) screener targets companies with yields above 5% that are described as well covered, growing and stable. That combination can help you focus on stocks where dividend strength is a key part of the investment case rather than an afterthought. In this article you will see three of the standouts from the...
NYSE:MTX
NYSE:MTXChemicals

Steep Q2 Loss Despite Higher Sales Might Change The Case For Investing In Minerals Technologies (MTX)

Minerals Technologies Inc. has reported past second-quarter 2026 results showing sales of US$548.4 million, up from US$528.9 million a year earlier, but swinging from net income of US$45.4 million to a net loss of US$183.6 million, alongside affirming a quarterly dividend of US$0.12 per share payable in September 2026. Despite higher sales, the sharp move to a basic loss per share of US$5.90 from earnings of US$1.44 highlights significant pressure on profitability that investors may need to...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Does Moderna’s Wider 2026 Loss Amid Pipeline Spend Change The Bull Case For MRNA?

In the past quarter, Moderna, Inc. reported second-quarter 2026 revenue of US$145 million versus US$142 million a year earlier, with a net loss of US$782 million and basic loss per share from continuing operations of US$1.97, while also updating investors on its norovirus and influenza vaccine programs. Across the first half of 2026, revenue rose to US$534 million from US$250 million, but the net loss widened to US$2.13 billion and basic loss per share from continuing operations increased to...
NYSE:PDM
NYSE:PDMOffice REITs

Piedmont Realty Trust (PDM) Reports Modest Growth And Narrower Loss, Is It Still Undervalued?

Piedmont Realty Trust (PDM) has moved into focus after reporting second quarter 2026 results that showed modest year over year growth in sales and revenue, along with a smaller net loss. See our latest analysis for Piedmont Realty Trust. Since those results on 28 July 2026, Piedmont Realty Trust’s share price has eased 2.7% over one day and 1.0% over the week. However, a 16.3% 90 day share price return and 32.4% one year total shareholder return indicate momentum building from earlier in the...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

Why NewAmsterdam Pharma (NAMS) Is Down 6.2% After EMA Backs Ubeslo And Evlarco Approval

NewAmsterdam Pharma and Menarini Group previously announced that the EMA’s CHMP issued a positive opinion recommending marketing authorization for Ubeslo (obicetrapib 10 mg) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg) in European patients with primary hypercholesterolemia and mixed dyslipidemia. This opinion, backed by extensive Phase 2 and Phase 3 data showing meaningful LDL-C reductions with placebo-like tolerability, could reshape NewAmsterdam’s commercial outlook through...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS) Cuts Growth View As Fair Value Stays In Focus

What Flowserve’s latest earnings and guidance updates mean for investors Flowserve (FLS) recently issued second quarter and six month 2026 results alongside revised full year and new third quarter guidance, giving investors fresh data on sales trends, profitability and updated growth expectations. The company now projects approximately 3% total sales growth for 2026, compared with its earlier 3% to 6% range. For the third quarter, Flowserve expects mid single digit total sales growth and net...
NYSE:CNO
NYSE:CNOInsurance

How Investors May Respond To CNO Financial (CNO) Raising 2026 Operating EPS Guidance by 8%

In July 2026, CNO Financial Group, Inc. raised its full-year 2026 operating earnings per share guidance by 8% at the midpoint, citing strong underlying fundamentals, improving profitability, and consistently repeatable results across its business. This upgraded outlook underscores management’s confidence in the durability of CNO’s operating model, reinforcing earlier expectations for margin expansion and more efficient capital deployment. Now we’ll examine how the upgraded 2026 operating...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

AXT (AXTI) Is Up 27.9% After Swing to Q2 Profit and Lumentum Supply Deal - What's Changed

AXT, Inc. reported second-quarter 2026 results showing sales of US$47.59 million and net income of US$11.13 million, alongside a long-term indium phosphide supply and capacity reservation agreement with Lumentum Operations, LLC that includes US$87,000,000 in deposits applied as shipment credits through 2031. These developments mark a shift from prior-period losses to profitability while securing multi-year product demand and upfront customer funding that could influence how investors view...
NYSE:CAT
NYSE:CATMachinery

Can Caterpillar (CAT) Justify Its Valuation As AI Data Center Optimism Meets Earnings?

Caterpillar stock in focus as AI data center theme meets upcoming earnings Caterpillar (CAT) is back on investors’ radar after recent analyst commentary highlighted its role in AI data center construction, with this AI driven demand story now intersecting with the company’s upcoming earnings report. See our latest analysis for Caterpillar. Caterpillar’s share price has been under pressure ahead of earnings, with a 30 day share price return that is down 17.81% and a 90 day share price return...
NYSE:PLOW
NYSE:PLOWMachinery

Is Douglas Dynamics (PLOW) A Bargain Before Its Q2 Earnings Report?

Upcoming Q2 report puts Douglas Dynamics in focus Douglas Dynamics (PLOW) is set to report its Q2 2026 results before the market opens on Monday, August 3, followed by an earnings call the same day, putting fresh attention on the stock. The market currently expects revenue to grow 12.9% year on year for the quarter, compared with a 2.8% decline in the same period last year. Analyst forecasts have generally been reaffirmed over the past month, indicating limited recent changes in external...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

The Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone

Arrowhead Pharmaceuticals recently reported that its Phase 3 SHASTA-3 and SHASTA-4 trials of plozasiran in severe hypertriglyceridemia met all primary and secondary endpoints, and it also completed global Phase 3 YOSEMITE trial enrollment for zodasiran in homozygous familial hypercholesterolemia. These advances signal meaningful momentum in Arrowhead’s late-stage cardiometabolic RNAi pipeline, potentially broadening future treatment options across rare and severe lipid disorders. Next, we’ll...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Old National Bancorp (ONB) Could Be 9% Undervalued Following Strong Earnings

How Old National Bancorp’s latest earnings event frames the stock Old National Bancorp (ONB) has drawn fresh attention after reporting second quarter 2026 results that included higher net interest income and net income compared with a year earlier, along with a completed share repurchase tranche and steady net charge offs. See our latest analysis for Old National Bancorp. Old National Bancorp’s recent earnings update and completed buyback have come alongside firm share price momentum, with an...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies (SPXC) Raised Full Year Guidance, Is The Upside Already Priced In?

SPX Technologies (SPXC) has moved into focus after its second quarter 2026 earnings update, which paired higher sales and earnings with upgraded full year guidance and a sharp one day share price reaction. See our latest analysis for SPX Technologies. The one day share price return of 10.2% after the earnings release comes against a quieter recent period, with a 30 day share price return of 5.22% lower and a year to date share price return of 8.05%, while the three year total shareholder...
NYSE:DT
NYSE:DTSoftware

Dynatrace (DT) Is Up 6.5% After Unveiling Autonomous SRE Agents And No-Code Builder – Has The Bull Case Changed?

In late July 2026, Dynatrace announced major enhancements to its Dynatrace Intelligence platform, introducing autonomous SRE agents, a no-code Agent Builder, and broader integrations with leading cloud and enterprise tools to automate incident triage and remediation under human oversight. Ahead of these product advances, Gremlin launched a native resilience-testing app for Dynatrace, and the company added Google engineering leader Chandu Thota to its board, underscoring a deeper push into...
NYSE:RNG
NYSE:RNGSoftware

RingCentral (RNG) Is Up 15.1% After Raising 2026 Guidance And Boosting Capital Returns – Has The Bull Case Changed?

In the past quarter, RingCentral reported higher revenue of US$657.01 million and a rise in net income to US$39.12 million, raised its full-year 2026 earnings guidance, and approved a higher quarterly dividend of US$0.125 per share while continuing share repurchases. NiCE’s announcement of an expanded, bi-directional partnership with RingCentral around UCaaS and contact center solutions highlights how tightly integrated AI-enabled communications are becoming central to the company’s business...
NasdaqGS:BANF
NasdaqGS:BANFBanks

Stronger Earnings and Lower Charge-Offs Might Change The Case For Investing In BancFirst (BANF)

BancFirst Corporation recently reported past second-quarter 2026 results, with net income rising to US$66.69 million and diluted EPS from continuing operations increasing to US$1.96, alongside lower net charge-offs of US$2.4 million compared with the same quarter a year earlier. For the first half of 2026, BancFirst’s net income reached US$129.68 million with higher earnings per share, suggesting that profitability improved even as credit costs eased. Next, we’ll examine how BancFirst’s...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Advanced Micro Devices (AMD) Could Be 6% Overvalued On Its New AI Infrastructure Push

Advanced Micro Devices (AMD) stock is in focus after the company used its Advancing AI 2026 event to launch a next generation AI infrastructure portfolio and announce several ecosystem partnerships. See our latest analysis for Advanced Micro Devices. Despite the Advancing AI 2026 announcements and a busy run of AI partnerships, AMD’s recent share price momentum has cooled, with the 7-day and 30-day share price returns down 8.77% and 11.97% respectively, while the 1-year total shareholder...
NYSE:APG
NYSE:APGConstruction

APi Group (APG) Following Raised Guidance And Deal Momentum Has An Undervalued Narrative

APi Group stock after Q2 earnings and raised 2026 guidance APi Group (APG) has put investors on alert after reporting second quarter 2026 results, lifting full year revenue guidance and outlining an active pipeline of bolt on acquisitions supported by artificial intelligence tools. See our latest analysis for APi Group. Despite the upbeat Q2 earnings and higher 2026 guidance, APi Group’s recent share price momentum has cooled, with a 30 day share price return down 5.03% and a 90 day share...